"Glycosylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The chemical or biochemical addition of carbohydrate or glycosyl groups to other chemicals, especially peptides or proteins. Glycosyl transferases are used in this biochemical reaction.
| Descriptor ID |
D006031
|
| MeSH Number(s) |
G02.111.158.812 G02.607.299 G03.191.812
|
| Concept/Terms |
Protein Glycosylation- Protein Glycosylation
- Glycosylation, Protein
- Glycosylations, Protein
- Protein Glycosylations
|
Below are MeSH descriptors whose meaning is more general than "Glycosylation".
Below are MeSH descriptors whose meaning is more specific than "Glycosylation".
This graph shows the total number of publications written about "Glycosylation" by people in this website by year, and whether "Glycosylation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 6 | 6 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2006 | 1 | 7 | 8 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 4 | 4 |
| 2010 | 1 | 8 | 9 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 7 | 7 |
| 2013 | 0 | 6 | 6 |
| 2014 | 0 | 5 | 5 |
| 2015 | 0 | 5 | 5 |
| 2016 | 0 | 9 | 9 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 5 | 5 |
| 2019 | 0 | 5 | 5 |
| 2020 | 0 | 10 | 10 |
| 2021 | 0 | 6 | 6 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glycosylation" by people in Profiles.
-
ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling. JCI Insight. 2024 Nov 22; 9(22).
-
Glycosylation in cancer as a source of biomarkers. Expert Rev Proteomics. 2024 Sep-Oct; 21(9-10):345-365.
-
Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation. Mol Genet Metab. 2024 Aug; 142(4):108513.
-
Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort. Mol Genet Metab. 2024 Aug; 142(4):108509.
-
N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins. Glycobiology. 2024 04 24; 34(6).
-
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation. Nat Commun. 2024 Feb 07; 15(1):1148.
-
circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression. J Exp Clin Cancer Res. 2023 Nov 23; 42(1):313.
-
Biallelic missense variants in COG3 cause a congenital disorder of glycosylation with impairment of retrograde vesicular trafficking. J Inherit Metab Dis. 2023 11; 46(6):1195-1205.
-
Immunomodulatory role of glycoRNAs in the brain. J Cereb Blood Flow Metab. 2023 04; 43(4):499-504.
-
SLC35A2-Related Epilepsy: Global Neuronal Consequences of a Focal Disruption in Glycosylation. Neurology. 2023 01 31; 100(5):225-226.